Taysha Gene Therapies, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -6,492.7% | -6,635.3% |
| FY2023 | — | -468.8% | -722.1% |
| FY2024 | — | -1,097.6% | -1,071.6% |
| FY2025 | — | -1,130.6% | -1,115.3% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -6,492.7% | -6,635.3% |
| FY2023 | — | -468.8% | -722.1% |
| FY2024 | — | -1,097.6% | -1,071.6% |
| FY2025 | — | -1,130.6% | -1,115.3% |